COPD trials in China

In China 87 Also abroad 557

87 trials · From ClinicalTrials.gov, checked 10 November 2026. Ask the study team whether a trial fits you.

No phaseTaking people
Dynamic Functional Imaging Phenotyping and Disease Progression Risk Assessment in COPD Using Dynamic Chest Radiography: A Multicenter Retrospective Study
Where
Guangzhou
Age
30 years to 85 years
People
2,500
Run by
Nanfang Hospital, Southern Medical University
See details and how to joinNCT07762573
No phaseNot yet taking people in China
Remote Intervention Versus Routine Monitoring in COPD Patients With Chronic Hypercapnia Receiving Home Non-invasive Respiratory Support
Where
Changsha, Hangzhou, Wenling, Zhengzhou
Age
40 years to 80 years
People
236
Run by
Sir Run Run Shaw Hospital
See details and how to joinNCT07751003
Phase 3Taking people
eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
Where
Beijing, Changchun, Changsha, Chengdu, Chongqing, Dongguan, Fujian, Guangzhou, Guilin, Haikou, Hangzhou, Harbin, Hefei, Hohhot, Huizhou, Jiangmen, Jinzhou, Nanchang, Nanjing, Nanning, Qinhuangdao, Shanghai, Shapingba, Shijiazhuang, Suining, Taiyuan, Taizhou, Ürümqi, Weifang, Wenzhou, Xiamen, Xinxiang, Yinchuan, Zunyi
Age
40 years to 75 years
People
1,196 worldwide
Run by
GlaxoSmithKline
See details and how to joinNCT07177339 · EU 2025-521108-23-00
No phaseTaking people
Effectiveness of DITM Versus IMT in COPD Patients
Where
Hangzhou, Lishui, Taizhou
Age
40 years and over
People
410
Run by
Sir Run Run Shaw Hospital
See details and how to joinNCT06958666
Phase 1Taking people
A Study of BBT002 in Healthy Volunteers (HVs) and in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Where
Chengdu, Guangzhou, Hangzhou, Hefei, Jiangmen, Nanchang, Qingyuan, Xinxiang, Xuzhou, Yichang
Age
18 years to 75 years
People
68
Run by
Bambusa Therapeutics
See details and how to joinNCT07288554
Phase 1/2Taking people
REGEND001 Autologous Basal Layer Stem Cell Transplantation for Chronic Obstructive Pulmonary Disease (COPD): A Translational Application Study
Where
Qionghai, Shanghai
Age
40 years to 80 years
People
20
Run by
Ruijin Hospital
See details and how to joinNCT06946953
No phaseTaking people
Exploring the Diagnostic Performance of Dynamic Chest Radiology in Chronic Obstructive Pulmonary Disease
Where
Guangzhou
Age
40 years to 80 years
People
2,500
Run by
Nanfang Hospital, Southern Medical University
See details and how to joinNCT06653413
Phase 1Taking people
A Phase I Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of HRS-9821 Powder for Inhalation Administered as a Single Dose in Healthy Participants and Multiple Doses in Patients With COPD
Where
Chengdu
Age
18 years to 75 years
People
48
Run by
Guangdong Hengrui Pharmaceutical Co., Ltd
See details and how to joinNCT07567872
Phase 1Not yet taking people in China
Study on Drug Interactions Affecting the Pharmacokinetics of RSS0343 Tablet
Where
Guangzhou
Age
18 years to 55 years
People
40
Run by
Reistone Biopharma Company Limited
See details and how to joinNCT07696091
No phaseTaking people
Endobronchial Silicone Valve for Patients With Emphysema
Where
Beijing
Age
18 years and over
People
147
Run by
China-Japan Friendship Hospital
See details and how to joinNCT07097896
No phaseTaking people
Effect of Spacer Use on Exacerbation Risk in High-Risk Older Adults With Chronic Airway Diseases Receiving Triple Therapy
Where
Harbin, Hefei, Ningbo, Ninghai, Taizhou
Age
65 years and over
People
380
Run by
First Affiliated Hospital of Ningbo University
See details and how to joinNCT07030881
No phaseNot yet taking people in China
Study on the Impact of Decolonization Treatment of Pneumocystis Jirovecii on the Frequency of Acute Exacerbation in COPD
Where
Chengdu, Guangzhou, Hangzhou, Huzhou, Jiaxing, Lishui, Nanchang, Quzhou, Shanghai, Shaoxing, Taizhou, Wenzhou, Wuhan
Age
40 years and over
People
630
Run by
Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT07665359
Phase 3Not yet taking people in China
A Phase 3 Clinical Trial to Evaluate the Safety and Efficacy of HSK39004 Inhalation Suspension in Patients With COPD
Where
Beijing
Age
40 years to 80 years
People
387
Run by
Haisco Pharmaceutical Group Co., Ltd.
See details and how to joinNCT07658339
Phase 3Taking people
A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Phase III Study of HSK39004 Inhalation Powder for the Treatment of COPD
Where
Beijing
Age
40 years to 80 years
People
376
Run by
Haisco Pharmaceutical Group Co., Ltd.
See details and how to joinNCT07583849
Phase 2Taking people
Evaluation of the Safety and Efficacy of HSK39004 Dry Powder Inhaler and HSK39004 Inhalation Suspension in Chinese Patients With Chronic Obstructive Pulmonary Disease (COPD)
Where
Nanchang
Age
40 years to 80 years
People
50
Run by
Haisco Pharmaceutical Group Co., Ltd.
See details and how to joinNCT07140328
No phaseTaking people
Air Purifier Use and Respiratory Health in COPD Patients
Where
Shanghai
Age
50 years to 80 years
People
120
Run by
Fudan University
See details and how to joinNCT07505602
Phase 3Not yet taking people in China
Long-Term Safety and Efficacy of HSK39004 Inhalation Suspension in COPD
Where
Nanchang
Age
40 years to 80 years
People
300
Run by
Haisco Pharmaceutical Group Co., Ltd.
See details and how to joinNCT07634367
Phase 2Taking people
A Study to Evaluate the Efficacy and Safety of RSS0343 Tablets in Patients With Chronic Obstructive Pulmonary Disease
Where
Guangzhou
Age
40 years to 80 years
People
300
Run by
Reistone Biopharma Company Limited
See details and how to joinNCT07349524
No phaseTaking people
A Translational Study for Prediction of Biomarkers and Identification of Phenotype and Endotype of COPD and Pre-COPD Outcomes in Chinese Population
Where
Beijing, Changsha, Chengdu, Guangzhou, Hefei, Nanjing, Nanning, Shanghai, Shenyang, Wuhan, Xuzhou, Zhengzhou
Age
30 years and over
People
850
Run by
AstraZeneca
See details and how to joinNCT06724848
No phaseNot yet taking people in China
Decision-making and Optimization of Ventilatory Support for AECOPD Patients
Where
Hangzhou
People
1,000
Run by
Sir Run Run Shaw Hospital
See details and how to joinNCT07508943
No phaseTaking people
Immune Status and Disease Control of Inflammatory Airway Diseases
Where
Ningbo
Age
18 years and over
People
200
Run by
First Affiliated Hospital of Ningbo University
See details and how to joinNCT07493629
Early phase 1Taking people
Treatment of Chronic Obstructive Pulmonary Disease (COPD) by REGEND007 Cell Therapy
Where
Yiwu
Age
40 years to 80 years
People
12
Run by
Regend Therapeutics
See details and how to joinNCT07355868
No phaseTaking people
Investigation and Classification of Treatable Traits in Patients With Chronic Airway Diseases
Where
Beijing
Age
20 years to 75 years
People
950
Run by
Beijing Chao Yang Hospital
See details and how to joinNCT07472738
No phaseNot yet taking people in China
Effectiveness of Xuanfei Jiangzhuo Decoction for Influenza-Induced AECOPD
Where
Tianjin
Age
60 years and over
People
300
Run by
Tianjin Medical University
See details and how to joinNCT07393685
No phaseTaking people
Predicting Risk Factors for Exacerbation of Chronic Obstructive Pulmonary Disease
Where
Shanghai
Age
40 years and over
People
200
Run by
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
See details and how to joinNCT03450603